Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

RTTNews | 1081 dagar sedan
Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

(RTTNews) - Pharmaceutical company Inhibikase Therapeutics, Inc. (IKT) announced Friday that the U.S. Food and Drug Administration (FDA) has reviewed its Investigational New Drug (IND) application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia (CML) and issued a Study May Procced (SMP) letter.

IkT-001Pro is a prodrug formulation of imatinib mesylate and has been developed to improve the safety of the first FDA-approved Abelson (Abl) kinase inhibitor, imatinib (marketed as Gleevec).

IkT-001Pro has the potential to be a safer alternative for patients and may improve the number of patients that reach and sustain major and/or complete cytogenetic responses in stable-phase CML.

In preclinical studies, IkT-001Pro was shown to be as much as 3.4 times safer than imatinib in non-human primates, reducing burdensome gastrointestinal side effects that occur following oral administration.

Imatinib delivered as IkT-001Pro was granted Orphan Drug Designation for stable-phase CML in September, 2018.

IkT-001Pro will be evaluated in a single ascending dose bioequivalence study and will enroll approximately 64 male and female healthy volunteers aged 25 to 55 who will receive IkT-001Pro at one of four doses.

For More Such Health News, visit rttnews.com

read more
Rate Cut Hopes Drag The Dollar Down

Rate Cut Hopes Drag The Dollar Down

The U.S. dollar declined against major currencies during the week ended August 8 amidst weak economic data that renewed hopes of a larger-than expected and higher-than-expected monetary policy easing by the Federal Reserve.
RTTNews | 24 minuter sedan
Bay Street Likely To Open Slightly Higher, But Weak Metal Prices Could Weigh

Bay Street Likely To Open Slightly Higher, But Weak Metal Prices Could Weigh

Canadian stocks may open with a slightly positive bias on Monday with investors looking ahead to the crucial U.S. inflation data due this week. The focus is also Trump administration's trade negotiations with China, and on the upcoming talks between the U.S. and Russia, aimed at bringing an end to the war in Ukraine.
RTTNews | 2h 37minuter sedan
FTSE 100 Up Marginally As Investors Look For Direction

FTSE 100 Up Marginally As Investors Look For Direction

The U.K. market is up in positive territory a little before noon on Monday with select counters attracting some strong buying interest. Uncertainty on the tariff front is rendering the mood a bit cautious and limiting the market's upside.
RTTNews | 4h 13minuter sedan
CAC 40 Drifts Lower In Lackluster Trade

CAC 40 Drifts Lower In Lackluster Trade

French stocks are down in negative territory on Monday as investors look for direction and make cautious moves while awaiting U.S. - Russia talks set to take place later in the week.
RTTNews | 4h 33minuter sedan
UK Job Placements Decline Sharply On Weaker Confidence & Budget Pressures

UK Job Placements Decline Sharply On Weaker Confidence & Budget Pressures

UK job placements logged a steep decline in July due to weaker confidence around the economic outlook and rising employment costs, monthly data from S&P Global showed Monday. Permanent staff appointments declined sharply in July and temp billings registered its biggest fall in five months, the KPMG/REC Report on Jobs said.
RTTNews | 5h 32minuter sedan